Impact of diabetes mellitus and body mass index on long-term survival in chronic total occlusion patients: a nationwide cohort study from the SCAAR registry

Résumé fourni par la source

Objectives To evaluate the effects of diabetes mellitus (DM) and body mass index (BMI) on long-term all-cause mortality in chronic total occlusion (CTO) patients. Design Retrospective, nationwide cohort study. Setting Swedish Coronary Angiography and Angioplasty Registry, between June 2015 and December 2021. Participants 24 284 patients with angiographically confirmed CTO. Prior coronary artery bypass graft surgery excluded. Subgroups were defined by DM status and BMI categories (underweight, healthy weight, overweight, obesity). Primary outcome measures Long-term all-cause mortality, assessed by Kaplan-Meier analysis and multivariable Cox proportional hazards regression. Results DM was present in 30.3% of patients and conferred a 31% higher risk of mortality (HR: 1.31, 95% CI: 1.20 to 1.42; p<0.001). Insulin use among patients with diabetes added a 52% increase in hazard (HR: 1.52; 95% CI: 1.38 to 1.67; p<0.001). BMI demonstrated a non-linear association with mortality: overweight (HR: 0.70, 95% CI: 0.64 to 0.77; p<0.001) and obese (HR: 0.74, 95% CI: 0.68 to 0.81; p<0.001) groups had lower risk compared with the healthy-weight group, whereas underweight individuals faced the highest risk (HR: 1.61, 95% CI: 1.25 to 2.08; p<0.001). A continuous BMI spline revealed an asymmetric U-shaped association: a steep increase in mortality below 23 kg/m 2 , lowest risk (nadir) at 32 kg/m 2 and modest rise above 35 kg/m 2 . Conclusions In this nationwide CTO cohort, DM independently predicted higher long-term mortality, accompanied by more severe comorbidities and greater CTO complexity, and insulin therapy further elevated hazard. Overweight and obese patients had better survival, while underweight individuals had the poorest prognosis. These findings underscore the importance of individualised risk assessment and management strategies in CTO patients, particularly those with DM or low BMI.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.